Societal CDMO, Inc. (NASDAQ:SCTL – Get Free Report) was up 0.9% during mid-day trading on Friday . The stock traded as high as $1.10 and last traded at $1.10. Approximately 514,600 shares traded hands during mid-day trading, a decline of 46% from the average daily volume of 957,342 shares. The stock had previously closed at $1.09.
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada reissued a “sector perform” rating and set a $1.10 price objective (down from $1.25) on shares of Societal CDMO in a research note on Thursday, February 29th.
Read Our Latest Research Report on Societal CDMO
Societal CDMO Trading Up 0.9 %
Societal CDMO (NASDAQ:SCTL – Get Free Report) last released its earnings results on Friday, March 22nd. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $27.72 million during the quarter, compared to analysts’ expectations of $25.50 million. Societal CDMO had a negative net margin of 14.03% and a negative return on equity of 23.82%. Equities research analysts predict that Societal CDMO, Inc. will post -0.08 EPS for the current fiscal year.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. AWM Investment Company Inc. lifted its holdings in Societal CDMO by 1.4% in the 3rd quarter. AWM Investment Company Inc. now owns 10,266,144 shares of the company’s stock valued at $4,815,000 after purchasing an additional 140,000 shares in the last quarter. Clear Harbor Asset Management LLC lifted its holdings in Societal CDMO by 174.5% in the 3rd quarter. Clear Harbor Asset Management LLC now owns 938,847 shares of the company’s stock valued at $440,000 after purchasing an additional 596,883 shares in the last quarter. Finally, Global Retirement Partners LLC lifted its holdings in Societal CDMO by 26.8% in the 1st quarter. Global Retirement Partners LLC now owns 71,462 shares of the company’s stock valued at $77,000 after purchasing an additional 15,112 shares in the last quarter. 87.15% of the stock is currently owned by hedge funds and other institutional investors.
Societal CDMO Company Profile
Societal CDMO, Inc, a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecules in the United States and internationally. The company provides end-to-end services, such as formulation development focusing on complex formulations, reformulation, physical characterization, and excipient compatibility; analytical methods development which offers a range of analytical testing capabilities, including product testing, ICH stability, method development and validation, chromatography and spectroscopy equipment, stability chambers, and microbial testing; and pharmaceutical manufacturing that provides milling, blending, compression, spray and rotary granulation, particle and bead coating, encapsulation, liquids, lyophilization, and sterile fill and finish services.
Read More
- Five stocks we like better than Societal CDMO
- Health Care Stocks Explained: Why You Might Want to Invest
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- The How and Why of Investing in Gold Stocks
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- How to Evaluate a Stock Before Buying
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Societal CDMO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Societal CDMO and related companies with MarketBeat.com's FREE daily email newsletter.